http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105596347-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-548 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-548 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 |
| filingDate | 2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105596347-B |
| titleOfInvention | Verticillin A and application in medicine preparation is combined with TRAIL |
| abstract | Present invention offer verticillin A is independent or the application in medicine for anti transfer of tumor is prepared is combined with TRAIL.Present invention research confirms that verticillin A can be effectively increased including human liver cancer cell, sensitiveness of the tumour cell including breast cancer cell and colon cancer cell to TRAIL.Clinically lack real medicine for anti transfer of tumor at present, therefore verticillin A have good application prospect.Verticillin A of the present invention can be effectively increased sensitiveness of the tumour cell to TRAIL at lower doses, and suppress Nasopharyngeal neoplasms in a manner of synergistic effect.Therefore verticillin A and combine with TRAIL with more preferable antitumor cell shift application prospect. |
| priorityDate | 2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 604.